Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · June 26, 2014

Adapalene/BPO Plus Doxycycline vs Oral Isotretinoin for Severe Nodular Acne

The British Journal of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Dermatology
A Treatment for Severe Nodular Acne: A Randomised Investigator-Blinded, Controlled,Non-Inferiority Trial Comparing Fixed-Dose Adapalene/BPO Plus Doxycycline vs OralIsotretinoin
Br J Dermatol 2014 Jun 16;[EPub Ahead of Print], J Tan, S Humphrey, R Vender, B Barankin, M Gooderham, N Kerrouche, F Audibert, C Lynde

Further Reading